8-K: Tivic Health Systems Faces Nasdaq Delisting Risk After Share Price Falls Below $1

Tivic Health Systems has received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement due to its stock price falling below $1 for 33 consecutive days.

Summary

• Tivic Health Systems received a notification from Nasdaq on June 28, 2024, stating that the company is not in compliance with the minimum bid price requirement.
• This is because the company's stock price has been below $1.00 per share for 33 consecutive business days.
• The company has 180 calendar days, until December 26, 2024, to regain compliance by having its stock price close at or above $1.00 for at least 10 consecutive business days.
• If the company fails to regain compliance within this period, it may be granted a second 180-day grace period if it meets other listing requirements and notifies Nasdaq of its intent to cure the deficiency.
• If compliance is not achieved within the allotted time, the company's stock may be subject to delisting from the Nasdaq Capital Market.
• The company intends to monitor its stock price and consider options to regain compliance.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the risk of delisting and the company's stock price falling below the minimum threshold. While there is a chance to regain compliance, the situation is concerning.

Positives

• The company has a 180-day period to regain compliance with the minimum bid price requirement.
• There is a possibility of a second 180-day grace period if certain conditions are met.
• The company intends to actively monitor the situation and consider options to regain compliance.

Negatives

• The company's stock price has been below $1.00 for 33 consecutive business days, triggering the non-compliance notification.
• There is a risk of delisting from the Nasdaq Capital Market if compliance is not regained.
• There is no guarantee that the company will regain compliance within the allotted time.

Risks

• The company faces the risk of delisting from the Nasdaq Capital Market if it cannot increase its stock price above $1.00.
• There is no assurance that the company will be able to regain compliance within the given time frame.
• The company's stock price may be negatively impacted by the delisting risk.

Future Outlook

The company intends to actively monitor its stock price and consider available options to resolve the deficiency and regain compliance with the Minimum Bid Price Requirement.

Management Comments

• The company intends to continue actively monitoring the closing bid price for the Company's common stock between now and December 26, 2024, and will consider available options to resolve the deficiency and regain compliance with the Minimum Bid Price Requirement.

Industry Context

This announcement is not specific to the industry but rather a company-specific issue related to its stock price performance. Many companies face similar delisting risks if their stock price falls below the minimum threshold set by exchanges.

Comparison to Industry Standards

• Many companies listed on Nasdaq face similar delisting risks if their stock price falls below $1.00.
• The 180-day compliance period is a standard procedure for companies in this situation.
• Other companies that have faced similar issues include those in the biotechnology and small-cap sectors, where stock price volatility is common.

Stakeholder Impact

• Shareholders may experience a decline in the value of their investment due to the delisting risk.
• Employees may be concerned about the company's future prospects.
• Creditors may be more cautious about lending to the company.

Next Steps

• The company will actively monitor its stock price.
• The company will consider available options to resolve the deficiency and regain compliance.
• The company may seek a second 180-day grace period if needed.

Key Dates

Keywords

Nasdaq, delisting, minimum bid price, compliance, stock price, Tivic Health Systems